ISSHLIdiopathic Sudden Sensorineural Hearing Loss
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
We compared the results on admission with those at a follow-up visit 3 months or more after the onset of ISSHL. The follow-up visit results were used as the control data.
A total of 97 patients with ISSHL were considered for inclusion in the study, of whom 51 did not consent to participate or did not attend their scheduled follow-up visit.
Patients were asked to note their perception of these items in the week before the onset of ISSHL, compared with how they typically experienced them over the previous year (Table 2).
Clinical ISSHL is an otologic emergency and must be evaluated carefully in addition to appropriate and specific treatment.
Several meta-analyses have suggested favorable results in salvage treatment with IT steroid for ISSHL after failure of primary treatment with systemic steroids [13-15].
In patients with ISSHL, the IT injections are made with different corticosteroid molecules and doses.
In this study, in the patient group, we investigated 90 patients admitted to the Otorhinolaryngology Department of Cumhuriyet University and diagnosed with ISSHL between 2014 and 2015.
Having a hearing loss of at least 30 dB in 3 consecutive frequencies in 72 h was defined as ISSHL [1].
All of the ISSHL patients underwent standard evaluation that consisted of pure-tone speech audiometry at the baseline and after the treatment (at the end of the 4th week), and the hearing data of all the control cases obtained at the baseline were gathered.
This study aimed to assess the effect of vasodilators compared with that of steroids on patients with ISSHL. Most of the studies did not compare steroids with vasodilators.
The results of this review show no beneficial effect of vasodilators on the treatment of ISSHL. No significant difference was observed between the intervention and control groups in the improvement of PTA despite higher cure rate in the intervention group.
Diagnosis and treatment of idiopathic sudden sensorineural hearing loss (ISSHL).